Senti Biosciences Holdings, Inc.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
SNTI$0.16-2.7%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. EXHIBITS
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit Number | Description | Schedule/Form | File No. | Exhibit | Filing Date |
| 10.1 | Amended and Restated Certificate of Incorporation of Senti Biosciences Holdings, Inc. | 8-K | 001-40440 | 3.1 | April 24, 2026 |
| 10.2 | Amended and Restated Bylaws of Senti Biosciences Holdings, Inc. | 8-K | 001-40440 | 3.2 | April 24, 2026 |
| 10.3 | Amended and Restated Designation Agreement, dated as of April 24, 2026, by and among Senti Biosciences Holdings, Inc., Senti Biosciences, Inc. and Celadon Partners SPV 24. | 8-K | 001-40440 | 10.1 | April 24, 2026 |
| 10.4 | Amended and Restated Designation Agreement, dated as of April 24, 2026, by and among Senti Biosciences Holdings, Inc., Senti Biosciences, Inc. and New Enterprise Associates 15, L.P. | 8-K | 001-40440 | 10.2 | April 24, 2026 |
| 10.5 | Assignment and Assumption Agreement, dated as of April 24, 2026, by and between Senti Biosciences, Inc. and Senti Biosciences Holdings, Inc. | 8-K | 001-40440 | 10.3 | April 24, 2026 |
| 10.6 | Senti Biosciences Holdings, Inc. Amended and Restated 2016 Stock Incentive Plan. | 8-K | 001-40440 | 10.4 | April 24, 2026 |
| 10.7 | Senti Biosciences Holdings, Inc. Amended and Restated 2022 Equity Incentive Plan. | 8-K | 001-40440 | 10.5 | April 24, 2026 |
| 10.8 | Senti Biosciences Holdings, Inc. Amended and Restated 2022 Inducement Plan. | 8-K | 001-40440 | 10.6 | April 24, 2026 |
| 10.9 | Senti Biosciences Holdings, Inc. Amended and Restated 2022 Employee Stock Purchase Plan. | 8-K | 001-40440 | 10.7 | April 24, 2026 |
| 10.10 | Securities Purchase Agreement, dated April 27, 2026, by and among Senti Biosciences Holdings, Inc., Senti Holdings, Inc., Senti Biosciences, Inc. and the purchaser named therein. | 8-K | 001-40440 | 10.1 | May 1, 2026 |
| 10.11 | Form of Senior Secured Convertible Note of Senti Holdings, Inc. | 8-K | 001-40440 | 10.2 | May 1, 2026 |
| 10.12 | Form of Guarantee. | 8-K | 001-40440 | 10.3 | May 1, 2026 |
| 10.13 | Form of Registration Rights Agreement, by and among Senti Biosciences Holdings, Inc., Senti Biosciences, Inc. and any investor to be named therein. | 8-K | 001-40440 | 10.4 | May 1, 2026 |
| 10.14 | Form of Voting Agreement by and among Senti Biosciences Holdings, Inc., Senti Biosciences, Inc. and the stockholders to be party thereto. | 8-K | 001-40440 | 10.5 | May 1, 2026 |
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| Incorporated by Reference | |||||
| Exhibit Number | Description | Schedule/Form | File No. | Exhibit | Filing Date |
|---|---|---|---|---|---|
| 31.2* | Certification of Principal Accounting and Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.2** | Certification of Principal Accounting and Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 101.INS* | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104* | The cover page for the Company’s Quarterly Report on Form 10-Q has been formatted in Inline XBRL and contained in Exhibit 101. | ||||
| * | Filed herewith. |
|---|---|
| ** | Furnished herewith. This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.